Reversible blocking of antibodies using bivalent peptide–DNA conjugates allows protease-activatable targeting

Brian M. G. Janssen, Edith H. M. Lempens, Luuk L. C. Olijve, Ilja K. Voets, Joost L. J. van Dongen, Tom F. A. de Greef, Maarten Merkx
  • Chemical Science, January 2013, Royal Society of Chemistry
  • DOI: 10.1039/c3sc22033h